COMPASS Pathways Announces Second Quarter 2023 Financial Results and Business Highlights  Psychedelics Investing
Goodness Growth Holdings Announces Voluntary Conversion of Super Voting Shares by its Executive Chairman Psychedelics Investing
Milestone in Psychedelic Wellness: Silo Wellness and NUGL's Share Exchange Paves Way for Expansion and Collaboration Psychedelics Investing
Jamaica Based Kaya Group Forges Partnership with Silo Wellness for Psychedelic Wellness Experiences and Retreats; Announces Share Exchange Agreement Psychedelics Investing
Melodiol To Streamline Portfolio With Up To A$30M Asset Sale To Us Listed Panacea – Maintaining Significant Stake In Spin-Off Vehicle Cannabis Investing News
Goodness Growth Holdings to Release Second Quarter 2023 Results on August 14, 2023 Psychedelics Investing
COMPASS Pathways plc to announce second quarter 2023 financial results on August 3, 2023 Psychedelics Investing
AMA Issues Details On First Psychedelics Therapy CPT Code – Thanks To These Psychedelic-Focused Mental Healthcare Companies Psychedelics Investing
First clinical study results of psilocybin treatment in anorexia nervosa published in Nature Medicine Psychedelics Investing
Melodiol Delivers Strong Start To Q3 Cy2023 With $1.6M In New Revenue And Confirmed POs Cannabis Investing News
COMPASS Pathways announces publication of positive data from treatment-resistant depression phase 2 clinical trial of COMP360 psilocybin alongside antidepressants in Nature journal, Neuropsychopharmacology Psychedelics Investing
